Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Conditions

• Cryopyrin-associated Periodic Syndromes
• Familial Cold Autoinflammatory Syndrome
• Muckle-Wells Syndrome
• Neonatal Onset Multisystem Inflammatory Disease

Interventions

• BIOLOGICAL: ACZ885

Sponsor

Novartis Pharmaceuticals